HilleVax (HLVX) Expected to Announce Quarterly Earnings on Wednesday

HilleVax (NASDAQ:HLVX) will likely be announcing its earnings results before the market opens on Wednesday, March 19th. Analysts expect the company to announce earnings of ($0.38) per share for the quarter.

HilleVax Price Performance

HLVX opened at $1.77 on Tuesday. The stock has a market capitalization of $88.16 million, a PE ratio of -0.57 and a beta of 0.76. The firm’s fifty day moving average price is $1.88 and its 200 day moving average price is $1.87. HilleVax has a 12-month low of $1.55 and a 12-month high of $18.00.

About HilleVax

HilleVax, Inc, a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. It develops HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company was formerly known as MokshaCo, Inc and changed its name to HilleVax, Inc in February 2021.